BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1123168)

  • 1. [Effect on short-term memory of classic antitubercular drugs used in the treatment of tuberculosis].
    Oleszkiewicz Z
    Gruzlica; 1975 Apr; 43(4):383-90. PubMed ID: 1123168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
    Czkwianianc M; Markiewicz I
    Przegl Lek; 1969 Jun; 25(6):479-81. PubMed ID: 5805095
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid-induced anaphylaxis.
    Crook MJ
    J Clin Pharmacol; 2003 May; 43(5):545-6. PubMed ID: 12751276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological evidence of peripheral nerve damage in patients treated with isoniazid.
    Bahemuka M; Kioy PM; Wanjama M; Wainaina CM
    East Afr Med J; 1982 Dec; 59(12):798-802. PubMed ID: 6191942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leukergy in patients with pulmonary tuberculosis treated for the first time with antitubercular drugs].
    Przemyska B
    Gruzlica; 1967; 35(11):1169-74. PubMed ID: 6063620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lupus and related syndromes: rare complication of long treatments with isoniazid and other antitubercular drugs (apropos of 2 new cases)].
    Delepierre F; Rullière R; Coury C
    Rev Tuberc Pneumol (Paris); 1971 Jun; 35(4):397-412. PubMed ID: 4108874
    [No Abstract]   [Full Text] [Related]  

  • 8. [Isoniazid-induced pleuro-pericarditis].
    Jouneau S; Volatron AC; Brinchault G; Morel V; Belleguic C; Delaval P
    Rev Pneumol Clin; 2003 Dec; 59(6):357-9. PubMed ID: 14745341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The elimination of chemotherapy side effects in pulmonary tuberculosis patients].
    Bal'tseva LB; Mel'nik GV; Man'ko VP
    Vrach Delo; 1990 Apr; (4):71-3. PubMed ID: 2275176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of antitubercular chemotherapy on immune status within the first 3 months of the start of short-term treatment].
    Cioflec D; Ion N; Tudorache V; Hudiţeanu O; Luţă V; Chira Z; Neagoe D; Stoienescu D; Jemna I; Sfetcu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(2):137-44. PubMed ID: 2849189
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cooperative study of short-term antibacillary treatments in 14 French centers].
    Brouet G
    Bull Int Union Tuberc; 1974; 49(1):398-410. PubMed ID: 4219734
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent-term therapeutic effects of short-course chemotherapy in rural outpatients with smear positive tuberculosis].
    Zhang YD
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Feb; 9(1):6-8, 61. PubMed ID: 3743281
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of agranulocytosis in long-term treatment of tuberculosis with Ethoxyd in combination with other antitubercular agents].
    Gol'dberg AS; Medved' RI
    Klin Med (Mosk); 1970 Dec; 48(12):43-7. PubMed ID: 5518596
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electroencephalographic changes and antitubercular treatments].
    Piéron R; Gautier H; Duhurt J; Kauffmann JP
    Sem Hop; 1972 Oct; 48(40):2585-91. PubMed ID: 4344846
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI; Stakhanov VA; Sharkova TI; Ivashchenko NA
    Probl Tuberk Bolezn Legk; 2003; (7):34-7. PubMed ID: 12939876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotype of isoniazid acetylation and tolerance of antitubercular drugs].
    Gontsa FT; Savina LA; Tsurkan VP; Kovalenko IP
    Probl Tuberk; 1988; (2):35-8. PubMed ID: 3375215
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled intermittent chemotherapy with isoniazid and the second line preparations].
    Utkin VV; Zhukova GN; Shmeleva VI
    Probl Tuberk; 1975; (6):22-6. PubMed ID: 1215343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].
    Lysov AV; Mordyk AV; Zatvornitskiĭ VA; Kondria AV
    Probl Tuberk Bolezn Legk; 2006; (9):45-8. PubMed ID: 17128801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime.
    Nolan CM
    Am J Respir Crit Care Med; 2003 Aug; 168(4):412-3. PubMed ID: 12912731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.